Anhedonia is not just a symptom of depression. It is one of the two core symptoms required for a diagnosis of major depressive disorder (MDD). Up to 70% to 75% of people with MDD experience it. In clinical terms, anhedonia refers to a loss of interest or pleasure in activities you previously enjoyed, and its presence (along with persistent low mood) is what separates a depressive episode from ordinary sadness or a rough patch.
Why Anhedonia Is Central to a Depression Diagnosis
The diagnostic criteria for major depressive disorder list nine possible symptoms, but two sit at the top: depressed mood and loss of interest or pleasure in almost all activities. To qualify for a diagnosis, you must have at least one of these two. You could technically meet the criteria for MDD without feeling classically “sad” if anhedonia is your dominant experience, alongside enough additional symptoms like sleep disruption, fatigue, or difficulty concentrating.
This matters because many people assume depression always looks like visible sadness or crying. For a significant number of people, the hallmark experience is instead a flatness: food doesn’t taste as good, hobbies feel pointless, time with friends feels like going through the motions. That numbness is anhedonia, and it’s a red flag even when it shows up without tears.
What Anhedonia Actually Feels Like
Anhedonia isn’t one uniform experience. Researchers break it into two distinct types that affect different parts of how you process pleasure.
Anticipatory anhedonia is a persistent reduction in the pleasure you expect to feel from future rewards. It’s the inability to look forward to things. A vacation, a favorite meal, seeing someone you love: intellectually you know these should excite you, but the feeling just isn’t there. This type is strongly connected to low mood and, in more severe cases, suicidal thinking.
Consummatory anhedonia is a reduction in the pleasure you feel in the moment when something good is actually happening. The meal is in front of you, your friends are around the table, and you feel nothing. This type tends to travel with sleep problems, difficulty concentrating, and feelings of worthlessness or guilt.
Most people with depression-related anhedonia experience some blend of both. But the distinction can be useful because it helps explain why “just doing the thing” doesn’t always work as advice. If someone has consummatory anhedonia, showing up to the party isn’t enough, because the reward system that would normally light up during the experience has gone quiet.
Physical Versus Social Anhedonia
Another way to understand anhedonia is by what it targets. Physical anhedonia is the loss of pleasure from sensory and everyday experiences: the smell of freshly cut grass, a warm bath, a cup of coffee, a beautiful view. These small pleasures that once provided a baseline of satisfaction simply stop registering.
Social anhedonia is the loss of pleasure from human connection. Friendships feel hollow. Spending time with people you care about feels like effort without payoff. The emotional warmth that normally comes from closeness, from caring for someone, from sharing an experience, dims or disappears entirely. People with social anhedonia often withdraw not because they dislike others, but because the emotional reward of being around people has vanished.
Both types can exist independently or overlap, and recognizing which one you’re dealing with can help clarify what feels “off” when you’re struggling to name it.
What Happens in the Brain
Anhedonia appears to be rooted in a malfunction of the brain’s reward circuit. This circuit runs on dopamine and connects several regions that together evaluate whether something is worth pursuing and whether it feels good once you get it. The key player is a small structure in the lower part of the brain called the nucleus accumbens, which acts as a hub, integrating signals to determine how rewarding a stimulus is.
In people with depression, neuroimaging consistently shows reduced activation of this reward circuit. The nucleus accumbens is less responsive, and the dopamine-producing neurons that feed into it fire in abnormal patterns. Animal studies have shown that this specific pathway, dopamine signals traveling to the nucleus accumbens, plays a direct role in stress vulnerability. When researchers artificially increased firing along this route in mice, it made them more susceptible to the behavioral equivalent of depression. The same effect didn’t occur when they stimulated dopamine pathways going to other brain regions.
This is why anhedonia can feel so biological and involuntary. It isn’t a choice to stop enjoying things. It’s the reward-processing machinery running at reduced capacity.
How Anhedonia Is Measured
Clinicians often use a standardized tool called the Snaith-Hamilton Pleasure Scale (SHAPS) to gauge the severity of anhedonia. It’s a 14-item questionnaire covering four areas: social interaction, food and drink, sensory experience, and hobbies or pastimes. You respond to statements like “I would enjoy a cup of tea or coffee” or “I would be able to enjoy a beautiful landscape” on a four-point scale from strongly agree to strongly disagree. A score of 3 or higher (out of a possible 14) indicates clinically meaningful anhedonia.
This tool is useful because it gives a concrete snapshot. Depression symptoms can be hard to articulate, especially when numbness is the dominant feeling. Having a structured way to identify where pleasure has dropped off can help both you and a clinician understand the full picture.
Treatment Challenges and Options
Anhedonia is one of the harder depression symptoms to treat. Standard antidepressants work primarily on serotonin, and while they can lift mood, reduce anxiety, and ease many depressive symptoms, their track record with anhedonia specifically is mixed. Some people find that their sadness lifts on medication but the flatness remains, or even worsens.
Medications that target dopamine in addition to serotonin tend to show better results for anhedonia. Bupropion, which boosts both dopamine and norepinephrine, has shown particular promise. Research suggests it may outperform serotonin-focused antidepressants for the motivational component of anhedonia, and it appears to work synergistically when combined with standard antidepressants. This makes sense given what we know about the dopamine-driven reward circuit underlying the symptom.
Newer treatments are also showing potential. A systematic review of ketamine studies found that every included trial reported improvement in anhedonia symptoms following treatment, regardless of how many sessions were administered. Neuroimaging from several of those trials confirmed that ketamine’s effect on anhedonia correlated with measurable changes in brain connectivity within the reward circuit. These findings are preliminary, but they’re notable because ketamine works through entirely different brain pathways than traditional antidepressants, offering a potential option for people whose anhedonia hasn’t responded to standard medication.
Anhedonia Beyond Depression
While anhedonia is most strongly associated with depression, it also shows up in other conditions. Social anxiety is one: anticipatory anhedonia is linked to avoidance of being the center of attention, while consummatory anhedonia connects to fear of embarrassment. Anhedonia also appears in schizophrenia, PTSD, substance use disorders, and Parkinson’s disease. Its presence across these conditions reinforces that it reflects a disruption in reward processing that can be triggered by multiple pathways, not just the ones involved in mood disorders.
If you’re experiencing a loss of pleasure without other obvious depression symptoms, that doesn’t mean it isn’t clinically significant. Anhedonia on its own is worth paying attention to, both as an early warning sign that something is shifting in your mental health and as a symptom that responds best to targeted treatment rather than a wait-and-see approach.

